NO330965B1 - Fremgangsmate for fremstilling av substituerte imidazolderivater, mellomprodukter anvendt i fremgangsmaten samt fremgangsmate for fremstilling av mellomprodukt - Google Patents

Fremgangsmate for fremstilling av substituerte imidazolderivater, mellomprodukter anvendt i fremgangsmaten samt fremgangsmate for fremstilling av mellomprodukt

Info

Publication number
NO330965B1
NO330965B1 NO20053712A NO20053712A NO330965B1 NO 330965 B1 NO330965 B1 NO 330965B1 NO 20053712 A NO20053712 A NO 20053712A NO 20053712 A NO20053712 A NO 20053712A NO 330965 B1 NO330965 B1 NO 330965B1
Authority
NO
Norway
Prior art keywords
preparation
imidazole derivatives
substituted imidazole
intermediates used
halogen
Prior art date
Application number
NO20053712A
Other languages
English (en)
Norwegian (no)
Other versions
NO20053712L (no
Inventor
Paivi Juujarvi
Seppo Parhi
Jaana Karjalainen
Original Assignee
Juvantia Pharma Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juvantia Pharma Ltd Oy filed Critical Juvantia Pharma Ltd Oy
Publication of NO20053712L publication Critical patent/NO20053712L/no
Publication of NO330965B1 publication Critical patent/NO330965B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20053712A 2003-01-08 2005-08-01 Fremgangsmate for fremstilling av substituerte imidazolderivater, mellomprodukter anvendt i fremgangsmaten samt fremgangsmate for fremstilling av mellomprodukt NO330965B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20030026A FI116292B (fi) 2003-01-08 2003-01-08 Menetelmä substituoitujen imidatsolijohdannaisten valmistamiseksi ja menetelmässä käytettäviä välituotteita
PCT/FI2004/000004 WO2004063168A1 (en) 2003-01-08 2004-01-08 Process for preparing substituted imidazole derivatives and intermediates used in the process

Publications (2)

Publication Number Publication Date
NO20053712L NO20053712L (no) 2005-08-01
NO330965B1 true NO330965B1 (no) 2011-08-29

Family

ID=8565279

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053712A NO330965B1 (no) 2003-01-08 2005-08-01 Fremgangsmate for fremstilling av substituerte imidazolderivater, mellomprodukter anvendt i fremgangsmaten samt fremgangsmate for fremstilling av mellomprodukt

Country Status (21)

Country Link
US (1) US7223871B2 (de)
EP (1) EP1581504B1 (de)
JP (1) JP4592680B2 (de)
KR (1) KR101079065B1 (de)
CN (1) CN100339368C (de)
AT (1) ATE425972T1 (de)
AU (1) AU2004203941B2 (de)
BR (1) BRPI0406676A (de)
CA (1) CA2511969C (de)
DE (1) DE602004020050D1 (de)
DK (1) DK1581504T3 (de)
ES (1) ES2322463T3 (de)
FI (1) FI116292B (de)
IL (1) IL168452A (de)
MX (1) MXPA05007217A (de)
NO (1) NO330965B1 (de)
NZ (1) NZ539831A (de)
PL (1) PL213564B1 (de)
PT (1) PT1581504E (de)
RU (1) RU2329253C2 (de)
WO (1) WO2004063168A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008003553A1 (es) * 2007-12-05 2009-11-27 Grindeks Jsc Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso
EP2456749B1 (de) 2009-07-24 2016-03-30 DSM Pharma Chemicals Regensburg GmbH Indanderivate zur verwendung als zwischenprodukte
WO2011014613A2 (en) * 2009-07-31 2011-02-03 Dr. Reddy's Laboratories Ltd. Preparation of fipamezole
EP2502917A1 (de) * 2011-03-17 2012-09-26 Santhera Pharmaceuticals (Schweiz) AG Im Festzustand kristalline Formen von 4-(2-Ethyl-5-fluor-2,3-dihydro-1H-inden-2-yl)-1H-imidazol
US12416024B2 (en) 2018-03-29 2025-09-16 Transworld Technologies Inc. Biologically enhanced oil recovery methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI833794A0 (fi) * 1983-10-18 1983-10-18 Farmos Oy Substituerade 2-merkapto-imidazoler
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
AU7040500A (en) 1999-09-06 2001-04-10 Lg Chem Investment Ltd. Process for preparing a 1-substituted 5-hydroxymethyl imidazole
US7091232B2 (en) 2002-05-21 2006-08-15 Allergan, Inc. 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds

Also Published As

Publication number Publication date
FI116292B (fi) 2005-10-31
AU2004203941A1 (en) 2004-07-29
IL168452A (en) 2009-07-20
KR20050091065A (ko) 2005-09-14
AU2004203941B2 (en) 2009-08-06
PL378179A1 (pl) 2006-03-06
PL213564B1 (pl) 2013-03-29
RU2329253C2 (ru) 2008-07-20
EP1581504A1 (de) 2005-10-05
PT1581504E (pt) 2009-05-26
JP4592680B2 (ja) 2010-12-01
CA2511969C (en) 2011-10-11
DK1581504T3 (da) 2009-06-29
US7223871B2 (en) 2007-05-29
JP2006515349A (ja) 2006-05-25
CN100339368C (zh) 2007-09-26
BRPI0406676A (pt) 2005-12-20
FI20030026L (fi) 2004-07-09
CN1723202A (zh) 2006-01-18
RU2005125044A (ru) 2006-01-20
ES2322463T3 (es) 2009-06-22
US20060025465A1 (en) 2006-02-02
NZ539831A (en) 2007-11-30
ATE425972T1 (de) 2009-04-15
MXPA05007217A (es) 2005-09-12
FI20030026A0 (fi) 2003-01-08
CA2511969A1 (en) 2004-07-29
EP1581504B1 (de) 2009-03-18
NO20053712L (no) 2005-08-01
KR101079065B1 (ko) 2011-11-02
WO2004063168A1 (en) 2004-07-29
DE602004020050D1 (de) 2009-04-30

Similar Documents

Publication Publication Date Title
PT2428519E (pt) Processo para preparação de 17-o-vinil-triflatos como intermediários
NO20051411L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk bruk derav samt intermediater til fremstilling derav
DE69912581D1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
NO20074763L (no) (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi
EP1338595A3 (de) Xanthin-Derivate als DPP-IV-Inhibitoren
WO2004103977A3 (en) Process for the preparation of pyrimidine derivatives
NO20074055L (no) Prosesser for a fremstille 4-(fenoksy-5-metylpyrimidin-4-yloksy)piperidin-1-karboksylsyrederivater og relaterte forbindelser
BRPI0406500A (pt) processo farmacêutico e compostos preparados pelo mesmo
DK1043310T3 (da) Biphenylamidinderivater
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
DE60112091D1 (de) Verfahren zur herstellung von azacycloalkanoylaminothiazolen
DE3786109D1 (de) Pyrido(2,3-d)pyrimidin-derivate.
DE602006008962D1 (de) Verfahren zur herstellung von valsartan
NO20070972L (no) Benzyloksyderivater som MAOB-inhibitorer
DK1489080T3 (da) Fremgangsmåde til frembringelse af cilostazol
FI20030026A0 (fi) Menetelmä substituoitujen imidatsolijohdannaisten valmistamiseksi ja menetelmässä käytettäviä välituotteita
GEP20074256B (en) Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
NO20063111L (no) Fremgangsmate for fremstilling av tiazolpyrimidiner
NO20052360L (no) Forbedrede formuleringer inneholdende substituerte imidazolderivater
MEP1708A (xx) Postupak proizvodnje thip-a
MY151167A (en) Benzimidazole compound
NO20064580L (no) Fremgangsmate for fremstilling av cefalosporinintermediater ved anvendelse av alfa-jodo-1-azetidin eddiksyreestere og trialkylfosfitter
MXPA05011859A (es) Nuevo compuesto intermedio para la preparacion de imidazopiridinas terapeuticamente activas.
AR067198A1 (es) Procesos para preparar carboxaldehido oxazina biciclico y un compuesto inhibidor de (beta) lactamasa y compuesto preparado durante alguno de los procesos

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees